AstraZeneca Pharma India Limited — Important, 21-01-2025: General Updates

The Writ petition filed by AstraZeneca Pharma India Limited in the High Court of Karnataka regarding the levy of improvement charges by Bruhat Bengaluru Mahanagara Palike (BBMP) has been dismissed. The court ruled against the petition on the grounds that a similar issue had already been addressed by a co-ordinate bench. The company is actively evaluating its legal options to challenge this decision. The financial implications of this dispute amount to ₹70.8 million (7.08 Cr), which has already been provisioned for in the company's accounts. This situation warrants close attention, as further developments in the legal proceedings could impact AstraZeneca's financial positioning.